This Biotech Stock 700%: Top Holding After $9.3M Sale
A biotech stock that surged 700% remains a cornerstone of many portfolios even after a sizable last-quarter sale by a...
Understand why methodology matters in investing and how it affects risk assessment, accuracy, and investment outcomes.
21,903 articlesA biotech stock that surged 700% remains a cornerstone of many portfolios even after a sizable last-quarter sale by a...
A dramatic 40% jump for Dyne Therapeutics has investors watching closely as a biotech-focused fund disclosed a sizabl...
Discover how to read arbe (arbe) 2025 earnings from the Q4 transcript, uncover management priorities, and turn insigh...
Dig into the drivers behind PAAS earnings and what they reveal about American silver mining. This guide explains how ...
A provocative SXSW moment spurred a wave of Gen Z investing chatter, with young traders leaning into memes, predictio...
So-Young's Q1 2026 results offer clues about growth momentum and profitability. This article breaks down the numbers,...
A Federal Reserve governor's message carries big weight for markets. This piece breaks down the implications of words...
As quantum tech moves from lab to real-world use, two stocks stand out for 2026. This guide explains why IonQ and IBM...
Starbucks shares have slipped sharply in a single week. This guide breaks down what’s driving the move, how to assess...
When the Fed's minutes hint at a shift, investors feel the tremor. This article breaks down what the uh-oh! meeting m...
Suze Orman urges parental restraint as a mom helps her 29-year-old daughter audit a Roth 401(K). The guidance spotlig...
As the renewables wave grows, Clearway Energy (CWEN) stands out with a diversified solar and wind portfolio. This gui...